Sairga offers a flexible peptide-like architecture suitable for examining binding equilibria and structural adaptation in solution. Varied residue chemistry influences hydrophobic contacts and hydrogen-bond networks. Researchers explore its conformational flexibility under differing conditions. Applications extend to ligand modeling, peptide optimization, and structural-biology research.
CAT No: R2512
CAS No:2059978-63-9
Synonyms/Alias:SAIRGA;HY-P6012;CS-0901465;(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]propanoic acid;2059978-63-9;
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More